APTIMA HPV assay performance in women with atypical squamous cells of undetermined significance cytology results

American Journal of Obstetrics and Gynecology

Volumn 208, Issue 2, 2013, Pages 144.e1-144.e8

  Stoler, Mark H ^a   Wright Jr , Thomas C ^b   Cuzick, Jack ^c   Dockter, Janel ^d   Reid, Jennifer L ^d   Getman, Damon ^d   Giachetti, Cristina ^d  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b New York Presbyterian Columbia University Medical Center   (United States)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d Gen Probe Incorporated   (United States)

Author keywords

APTIMA human papillomavirus assay; atypical squamous cells of undetermined significance; cervical cancer; human papillomavirus; Papanicolaou test; triage

Indexed keywords

ADENOCARCINOMA; ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS DNA TEST; LABORATORY TEST; PAPANICOLAOU TEST; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL; UTERINE CERVIX CARCINOMA IN SITU;

EID: 84872865801     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2012.12.003     Document Type: Article

References (34)

1. E.P. Whitlock, K.K. Vesco, M. Eder, J.S. Lin, C.A. Senger, B.U. Burda Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the US Preventive Services Task Force Ann Intern Med 155 2011 687 697
2. M. Arbyn, C. Bergeron, P. Klinkhamer, P. Martin-Hirsch, A.G. Siebers, J. Bulten Liquid compared with conventional cervical cytology: a systematic review and meta-analysis Obstet Gynecol 111 2008 167 177
3. Agency for Health Care Policy and Research (AHCPR) Evaluation of cervical cytology Summary, evidence report/technology assessment: number 5, January 1999 http://www.ncbi.nlm.nih.gov/books/NBK32961/ Accessed April 28, 2012
4. J.M. Walboomers, M.V. Jacobs, M.M. Manos Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 1999 12 19
5. IARC Press IARC handbooks of cancer prevention, volume 10 Cervix cancer screening www.iarc.fr/en/publications/pdfs-online/./handbook10-cover.pdf 2005 Accessed April 28, 2012
6. J. Cuzick, C. Clavel, K.U. Petry Overview of the European and North American studies on HPV testing in primary cervical cancer screening Int J Cancer 119 2006 1095 1101
7. P. Naucler, W. Ryd, S. Törnberg Human papillomavirus and Papanicolaou tests to screen for cervical cancer N Engl J Med 357 2007 1589 1597
8. D. Saslow, D. Solomon, H.W. Lawson American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer CA Cancer J Clin 62 2012 147 172
9. T.C. Wright Jr, L.S. Massad, C.J. Dunton, M. Spitzer, E.J. Wilkinson, D. Solomon 2006 American Society for Colposcopy and Cervical Pathology-sponsored consensus conference 2006 Consensus guidelines for the management of women with abnormal cervical cancer screening tests Am J Obstet Gynecol 197 2007 346 355
10. M. Arbyn, G. Ronco, C.J. Meijer, P. Naucler Trials comparing cytology with human papillomavirus screening Lancet Oncol 10 2009 935 936
11. G. Koliopoulos, M. Arbyn, P. Martin-Hirsch, M. Kyrgiou, W. Prendiville, E. Paraskevaidis Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies Gynecol Oncol 104 2007 232 246
12. M. Plummer, M. Schiffman, P.E. Castle, D. Maucort-Boulch, C.M. Wheeler ALTS Group A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion J Infect Dis 195 2007 1582 1589
13. R. Klaes, T. Friedrich, D. Spitkovsky Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri Int J Cancer 92 2001 276 284
14. H. zur Hausen Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types Curr Top Microbiol Immunol 186 1994 131 156
15. K. Münger, A. Baldwin, K.M. Edwards Mechanisms of human papillomavirus-induced oncogenesis J Virol 78 2004 11451 11460
16. K. Sotlar, A. Stubner, D. Diemer Detection of high-risk human papillomavirus E6 and E7 oncogene transcripts in cervical scrapes by nested RT-polymerase chain reaction J Med Virol 74 2004 107 116
17. K. Cuschieri, N. Wentzensen Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia Cancer Epidemiol Biomarkers Prev 17 2008 2536 2545
18. J. Dockter, A. Schroder, C. Hill, L. Guzenski, J. Monsonego, C. Giachetti Clinical performance of the APTIMA HPV assay for the detection of high-risk HPV and high-grade cervical lesions J Clin Virol 45 2009 S55 S61
19. P.E. Castle, J. Dockter, C. Giachetti A cross-sectional study of a prototype carcinogenic human papillomavirus E6/E7 messenger RNA assay for detection of cervical precancer and cancer Clin Cancer Res 13 2007 2599 2605
20. A. Szarewski, L. Ambroisine, L. Cadman Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears Cancer Epidemiol Biomarkers Prev 17 2008 3033 3042
21. M. Reuschenbach, A. Clad, C. von Knebel Doeberitz Performance of p16INK4a-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results Gynecol Oncol 119 2010 98 105
22. J. Monsonego, M.G. Hudgens, L. Zerat Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: The FASE study Int J Cancer 129 2010 691 701
23. D. Solomon, D. Davey, R. Kurman The 2001 Bethesda System: terminology for reporting results of cervical cytology JAMA 287 2002 2114 2119
24. T.C. Wright, B.M. Ronnett, R.J. Kurman, A. Ferenczy Precancerous lesions of the cervix R.J. Kurman, L.H. Ellenson, B.M. Ronnett, Blaustein's pathology of the female genital tract 6th ed. 2011 Springer New York
25. Gen-Probe Inc Gen-Probe APTIMA HPV Assay [package insert] 2008 Gen-Probe Inc San Diego, CA
26. Digene Corp Digene Hybrid Capture 2 High-Risk HPV DNA Test [package insert] 2007 Digene Corp Gaithersburg, MD
27. A. Agresti, B.A. Coull Approximate is better than "exact" for interval estimation of binomial proportions Am Statistician 52 1998 119 126
28. M. Kondratovich Comparing two medical tests when results of reference standard are unavailable for those negative via both tests J Biopharm Stat 18 2008 145 166
29. ALTS Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance Am J Obstet Gynecol 188 2003 1383 1392
30. M.H. Stoler, M.D. Vichnin, A. Ferenczy The accuracy of colposcopic biopsy: analyses from the placebo arm of the Gardasil clinical trials Int J Cancer 128 2011 1354 1362
31. M.H. Stoler, P.E. Castle, D. Solomon, M. Schiffman The Expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well-validated assays Am J Clin Pathol 127 2007 1 3
32. M. Schiffman, C.M. Wheeler, A. Dasgupta, D. Solomon, P.E. Castle ALTS Group A comparison of a prototype PCR assay and hybrid capture 2 for detection of carcinogenic human papillomavirus DNA in women with equivocal or mildly abnormal Papanicolaou smears Am J Clin Pathol 124 2005 722 732
33. R.G. Pretorius, W.H. Zhang, J.L. Belinson Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse Am J Obstet Gynecol 191 2004 430 434
34. R.G. Pretorius, R.J. Kim, J.L. Belinson, P. Elson, Y.L. Qiao Inflation of sensitivity of cervical cancer screening tests secondary to correlated error in colposcopy J Low Genit Tract Dis 10 2006 5 9